CoChat
Sign Up
Cited by 243

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Microarray Analysis of Hippocampal CA1 Neurons Implicates Early Endosomal Dysfunction During Alzheimer's Disease Progression

Ginsberg, Stephen D., Alldred, Melissa J., Counts, Scott E., Cataldo, Anne M., Neve, Rachael L., Jiang, Ying, Wuu, Joanne, Chao, Moses V., Mufson, Elliott J., Nixon, Ralph A., Che, Shaoli·2010·Biological Psychiatry
DOI 10.1016/j.biopsych.2010.05.030PMC PMC2965820
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2010.05.030

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • RAB10 plays a role in endocytosis, which has been implicated in Alzheimer's disease.

    “RAB10 plays a role in endocytosis, which has been implicated in AD [56, 57]”

    From Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience (2017) · cites this paper as [56]

    The Discussion links abnormal endocytosis and endosomal trafficking to AD. The Results mention rab10 but report no differential regulation of it; they do not establish that RAB10 itself plays a role in endocytosis. Thus the paper supports the AD–endocytosis link, but not the RAB10-specific part of the claim. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 51

  1. Kordower, 2001, Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment, Ann Neurol, 49, 202, 10.1002/1531-8249(20010201)49:2<202::AID-ANA40>3.0.CO;2-3 · DOI
  2. Cataldo, 2000, Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: Differential effects of APOE genotype and presenilin mutations, Am J Pathol, 157, 277, 10.1016/S0002-9440(10)64538-5 · DOI · Paper page
  3. Cataldo, 2001, Endocytic disturbances distinguish among subtypes of Alzheimer's disease and related disorders, Ann Neurol, 50, 661, 10.1002/ana.1254 · DOI · Paper page
  4. Howe, 2004, Signaling endosome hypothesis: A cellular mechanism for long distance communication, J Neurobiol, 58, 207, 10.1002/neu.10323 · DOI
  5. Delcroix, 2004, Trafficking the NGF signal: Implications for normal and degenerating neurons, Prog Brain Res, 146, 3
  6. Valdez, 2007, Trk-signaling endosomes are generated by Rac-dependent macroendocytosis, Proc Natl Acad Sci U S A, 104, 12270, 10.1073/pnas.0702819104 · DOI · Paper page
  7. Bronfman, 2007, Endosomal transport of neurotrophins: Roles in signaling and neurodegenerative diseases, Dev Neurobiol, 67, 1183, 10.1002/dneu.20513 · DOI
  8. Deinhardt, 2006, Rab5 and rab7 control endocytic sorting along the axonal retrograde transport pathway, Neuron, 52, 293, 10.1016/j.neuron.2006.08.018 · DOI
  9. Liu, 2007, Nerve growth factor-mediated neurite outgrowth via regulation of Rab5, Mol Biol Cell, 18, 1375, 10.1091/mbc.E06-08-0725 · DOI
  10. Saxena, 2005, The small GTPase Rab7 controls the endosomal trafficking and neuritogenic signaling of the nerve growth factor receptor TrkA, J Neurosci, 25, 10930, 10.1523/JNEUROSCI.2029-05.2005 · DOI
  11. Mufson, 2006, Neuronal gene expression profiling: Uncovering the molecular biology of neurodegenerative disease, Prog Brain Res, 158, 197, 10.1016/S0079-6123(06)58010-0 · DOI
  12. Ginsberg, 2006, Single cell gene expression profiling in Alzheimer's disease, NeuroRx, 3, 302, 10.1016/j.nurx.2006.05.007 · DOI
  13. Ginsberg, 2000, Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons, Ann Neurol, 48, 77, 10.1002/1531-8249(200007)48:1<77::AID-ANA12>3.0.CO;2-A · DOI
  14. Ginsberg, 2006, Downregulation of trk but not p75 gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease, J Neurochem, 97, 475, 10.1111/j.1471-4159.2006.03764.x · DOI
  15. Ginsberg, 2006, Shift in the ratio of three-repeat tau and four-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease, J Neurochem, 96, 1401, 10.1111/j.1471-4159.2005.03641.x · DOI · Paper page
  16. Counts, 2007, {Alpha}7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease, Arch Neurol, 64, 1771, 10.1001/archneur.64.12.1771 · DOI
  17. Ginsberg, 2005, Expression profile analysis within the human hippocampus: Comparison of CA1 and CA3 pyramidal neurons, J Comp Neurol, 487, 107, 10.1002/cne.20535 · DOI
  18. Che, 2004, Amplification of transcripts using terminal continuation, Lab Invest, 84, 131, 10.1038/labinvest.3700005 · DOI
  19. Ginsberg, 2008, Transcriptional profiling of small samples in the central nervous system, Methods Mol Biol, 439, 147, 10.1007/978-1-59745-188-8_10 · DOI
  20. Alldred, 2008, Terminal continuation (TC) RNA amplification enables expression profiling using minute RNA input obtained from mouse brain, Int J Mol Sci, 9, 2091, 10.3390/ijms9112091 · DOI
  21. Alldred, 2009, Terminal continuation (TC) RNA amplification without second strand synthesis, J Neurosci Methods, 177, 381, 10.1016/j.jneumeth.2008.10.027 · DOI
  22. Jiang, 2010, Alzheimer's-related endosome dysfunction in Down syndrome is A{beta}-independent but requires APP and is reversed by BACE-1 inhibition, Proc Natl Acad Sci U S A, 107, 1630, 10.1073/pnas.0908953107 · DOI
  23. Counts, 2004, Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease, Ann Neurol, 56, 520, 10.1002/ana.20233 · DOI
  24. Cataldo, 2008, Down syndrome fibroblast model of Alzheimer-related endosome pathology: Accelerated endocytosis promotes late endocytic defects, Am J Pathol, 173, 370, 10.2353/ajpath.2008.071053 · DOI
  25. Coopersmith, 1999, Expression of multiple proteins within single primary cortical neurons using a replication deficient HSV vector, BioTechniques, 27, 1156, 10.2144/99276st01 · DOI
  26. Kajiya, 2008, Brain-derived neurotrophic factor stimulates bone/cementum-related protein gene expression in cementoblasts, J Biol Chem, 283, 16259, 10.1074/jbc.M800668200 · DOI
  27. Wozniak, 2009, Alzheimer's disease-specific tau phosphorylation is induced by herpes simplex virus type 1, J Alzheimers Dis, 16, 341, 10.3233/JAD-2009-0963 · DOI · Paper page
  28. Wozniak, 2007, Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation, Neurosci Lett, 429, 95, 10.1016/j.neulet.2007.09.077 · DOI
  29. Mufson, 2002, Single cell gene expression profiles of nucleus basalis cholinergic neurons in Alzheimer's disease, Neurochem Res, 27, 1035, 10.1023/A:1020952704398 · DOI
  30. Mufson, 2008, Cholinergic system during the progression of Alzheimer's disease: Therapeutic implications, Expert Rev Neurother, 8, 1703, 10.1586/14737175.8.11.1703 · DOI
  31. Yuyama, 2009, Late endocytic dysfunction as a putative cause of amyloid fibril formation in Alzheimer's disease, J Neurochem, 109, 1250, 10.1111/j.1471-4159.2009.06046.x · DOI
  32. Nixon, 2004, Niemann-Pick type C disease and Alzheimer's disease: The APP-endosome connection fattens up, Am J Pathol, 164, 757, 10.1016/S0002-9440(10)63163-X · DOI
  33. Lambert, 2009, Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease, Nat Genet, 41, 1094, 10.1038/ng.439 · DOI · Paper page
  34. Peng, 2004, Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease, J Neuropathol Exp Neurol, 63, 641, 10.1093/jnen/63.6.641 · DOI
  35. Vepsalainen, 2005, Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease, J Neurol, 252, 423, 10.1007/s00415-005-0667-5 · DOI
  36. Chen, 2008, Genetic association of neurotrophic tyrosine kinase receptor type 2 (NTRK2) with Alzheimer's disease, Am J Med Genet B Neuropsychiatr Genet, 147, 363, 10.1002/ajmg.b.30607 · DOI
  37. Cozza, 2008, SNPs in neurotrophin system genes and Alzheimer's disease in an Italian population, J Alzheimers Dis, 15, 61, 10.3233/JAD-2008-15105 · DOI
  38. Bao, 2000, Threonine phosphorylation diverts internalized epidermal growth factor receptors from a degradative pathway to the recycling endosome, J Biol Chem, 275, 26178, 10.1074/jbc.M002367200 · DOI
  39. Madshus, 2009, Internalization and intracellular sorting of the EGF receptor: A model for understanding the mechanisms of receptor trafficking, J Cell Sci, 122, 3433, 10.1242/jcs.050260 · DOI
  40. Stern, 2007, Epidermal growth factor receptor fate is controlled by Hrs tyrosine phosphorylation sites that regulate Hrs degradation, Mol Cell Biol, 27, 888, 10.1128/MCB.02356-05 · DOI
  41. Grbovic, 2003, Rab5-stimulated up-regulation of the endocytic pathway increases intracellular beta-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Abeta production, J Biol Chem, 278, 31261, 10.1074/jbc.M304122200 · DOI
  42. Cirrito, 2008, Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo, Neuron, 58, 42, 10.1016/j.neuron.2008.02.003 · DOI · Paper page
  43. Tong, 2004, Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons, J Neurosci, 24, 6799, 10.1523/JNEUROSCI.5463-03.2004 · DOI · Paper page
  44. Poon, 2009, Beta-amyloid impairs axonal BDNF retrograde trafficking, Neurobiol Aging
  45. Arancibia, 2008, Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats, Neurobiol Dis, 31, 316, 10.1016/j.nbd.2008.05.012 · DOI
  46. Nagahara, 2009, Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease, Nat Med, 15, 331, 10.1038/nm.1912 · DOI · Paper page
  47. Lin, 2007, Neuroprotection by small molecule activators of the nerve growth factor receptor, J Pharmacol Exp Ther, 322, 59, 10.1124/jpet.106.118034 · DOI
  48. Longo, 2007, Small molecule neurotrophin receptor ligands: Novel strategies for targeting Alzheimer's disease mechanisms, Curr Alzheimer Res, 4, 503, 10.2174/156720507783018316 · DOI
  49. Skaper, 2008, The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors, CNS Neurol Disord Drug Targets, 7, 46, 10.2174/187152708783885174 · DOI
  50. Rajagopal, 2004, Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes, J Neurosci, 24, 6650, 10.1523/JNEUROSCI.0010-04.2004 · DOI
  51. Huang, 2008, Zinc-mediated transactivation of TrkB potentiates the hippocampal mossy fiber-CA3 pyramid synapse, Neuron, 57, 546, 10.1016/j.neuron.2007.11.026 · DOI

Cited by

Sorted by citations

Metadata

Authors
Ginsberg, S. D., Alldred, M. J., Counts, S. E., Cataldo, A. M., Neve, R. L., Jiang, Y., Wuu, J., Chao, M. V., Mufson, E. J., Nixon, R. A., & Che, S.
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2010-11
Volume
68
Issue
10
Pages
885-893
ISSN
0006-3223
DOI
10.1016/j.biopsych.2010.05.030
PMC
PMC2965820
Cited by
243
References
5
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • National Institutes of Health (AG17617, AG14449, AG10161, AG09466)
  • Alzheimer's Association

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review